Bayer enjoys summertime. Bayer brings this summer’s M&A highlight with the sale of its veterinary medicine division to Elanco for approx. USD 7.6 billion. Together with Lanxess, Bayer also sells chemical park operator Currenta to Macquarie for a transaction volume of approx. EUR 3.5 billion. Finally, Bayer lets go of Dr. Scholl’s foot treatment articles to financial investor Yellow Wood for approx. USD 585 million. Japanese speciality chemicals company DIC cinches BASF’s pigment business for approx. EUR 985 million. Volkswagen and Northvolt establish a joint venture to manufacture lithium-ion batteries and China Railway Rolling Stock Corporation succeeds in entering the European market with its acquisition of Vossloh’s European locomotive business. Continue reading.